We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Immunovia carried out the study with an undisclosed global pharma company and found that its IMMray could differentiate healthy controls from NSCLC samples with a 95% accuracy. The
In conjunction with the merger the new entity also received an investment from Ampersand Capital Partners to continue expanding the company in the rapidly evolving cell and gene therapy
The company previously received approval from the FSFB’s Ethics Committee. Hancock Jaffe will now begin gathering the information necessary to submit an application for approval to Instituto Nacional
This partnership intends to make readily available life-saving devices for every out-of-hospital cardiac arrest. Recent figures show that public access defibrillators are used in less than 3% of
Eye infections can be very serious and lead to the loss of sight. However, in the UK and throughout the developed world, these are readily diagnosed and treated
GyroGear, which was founded by former Imperial alumnus Dr Faii Ong, is developing wearable technology that can improve quality of life for people who suffer from hand tremors
The Cerenovus BRAVO Flow Diverter will divert blood flow from the aneurysm and promote healing thereby reducing the risk of rupture, a main cause of hemorrhagic stroke. With
SCOUT is claimed to be the only wire-free breast localization system that uses radar to mark a lumpectomy or biopsy site, with no significant artifacts on magnetic resonance
Cerveau said the expansion is being driven by the increasing interest of [18F]MK-6240 as a developmental and investigational tool in clinical trials. The company said NFTs made up
The trial will assess the safety and effectiveness of the Viveve System for improving the sexual function of women following vaginal childbirth. The FDA approval was based on